ResearcherOrcidActive in the last 2 years
Rei Okada
Matched on ORCID iD 0000-0003-2369-4642. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- Preoperative low C-reactive protein-albumin-lymphocyte (CALLY) index is a poor prognostic indicator for overall survival in patients undergoing surgery for pan… Co-author DOI 10.1007/s00595-026-03270-8↗
- Low prealbumin level is a poor prognostic biomarker for surgically treated pancreatic cancer. Co-author DOI 10.3892/mco.2025.2856↗
- Are preoperative high soluble programmed death ligand 1 levels responsible for patients’ poor prognoses in hepato-biliary-pancreatic cancer? Co-author DOI 10.21203/rs.3.rs-52812/v2↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hideaki Shimada · 3 shared papers, 2020–2026 · strength 0.67
- Paper Preoperative low C-reactive protein-albumin-lymphocyte (CALLY) index is a poor prognostic indicator for overall surviva… DOI 10.1007/s00595-026-03270-8↗
- Paper Low prealbumin level is a poor prognostic biomarker for surgically treated pancreatic cancer. DOI 10.3892/mco.2025.2856↗
- Paper Are preoperative high soluble programmed death ligand 1 levels responsible for patients’ poor prognoses in hepato-bilia… DOI 10.21203/rs.3.rs-52812/v2↗
- Yu Matsumoto · 2 shared papers, 2025–2026 · strength 0.56
- Tetsuya Maeda · 2 shared papers, 2020–2025 · strength 0.36
- Hironori Kaneko · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.